{"id":"once-daily-insulin-detemir","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL2104391","moleculeType":"Protein","molecularWeight":"5916.93"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin detemir is a modified human insulin analog with a fatty acid chain attached, which allows it to bind reversibly to albumin in the bloodstream, creating a depot effect that extends its duration of action to approximately 24 hours. This provides steady basal insulin coverage with a relatively flat pharmacokinetic profile, reducing the risk of hypoglycemic episodes compared to shorter-acting insulins. It is administered once daily and is used to maintain baseline insulin levels in patients with type 1 and type 2 diabetes.","oneSentence":"Insulin detemir is a long-acting basal insulin that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues while suppressing hepatic glucose production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:24:16.523Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus in pediatric patients"},{"name":"Type 2 diabetes mellitus in pediatric patients"}]},"trialDetails":[{"nctId":"NCT01239550","phase":"NA","title":"Insulin Detemir in Obesity Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2011-04","conditions":"Diabetes, Obesity","enrollment":240},{"nctId":"NCT02496780","phase":"PHASE2, PHASE3","title":"The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients","status":"TERMINATED","sponsor":"University of Minnesota","startDate":"2015-08","conditions":"Cystic Fibrosis","enrollment":65},{"nctId":"NCT02871089","phase":"NA","title":"Closed Loop From Onset in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 1 Diabetes","enrollment":96},{"nctId":"NCT00455858","phase":"PHASE4","title":"Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":87},{"nctId":"NCT00521690","phase":"PHASE4","title":"The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-12","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":25},{"nctId":"NCT00506662","phase":"PHASE4","title":"Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2007-07","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT01100892","phase":"PHASE3","title":"Cystic Fibrosis - Insulin Deficiency, Early Action","status":"COMPLETED","sponsor":"Sydney Children's Hospitals Network","startDate":"2010-12","conditions":"Cystic Fibrosis, Diabetes","enrollment":100},{"nctId":"NCT03377699","phase":"PHASE3","title":"Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2017-11-22","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":225},{"nctId":"NCT02967224","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulins in Insulin Naïve Patients Initiating Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-05","conditions":"Diabetes Mellitus, Type 2","enrollment":705},{"nctId":"NCT02967211","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulin in Patients Already Using Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12-21","conditions":"Diabetes Mellitus, Type 2","enrollment":609},{"nctId":"NCT04965051","phase":"NA","title":"Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-08","conditions":"Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range","enrollment":40},{"nctId":"NCT03001323","phase":"NA","title":"Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis","status":"TERMINATED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2017-01","conditions":"Diabetes Mellitus","enrollment":27},{"nctId":"NCT02846233","phase":"NA","title":"Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-08","conditions":"Type 2 Diabetes Mellitus","enrollment":22},{"nctId":"NCT02556918","phase":"PHASE4","title":"Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Hyperglycemia","enrollment":202},{"nctId":"NCT01966978","phase":"PHASE4","title":"The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2014-11","conditions":"Diabetes Mellitus, Type 2, Diabetes","enrollment":157},{"nctId":"NCT02451137","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-06-16","conditions":"Diabetes Mellitus, Type 2","enrollment":3304},{"nctId":"NCT01232946","phase":"NA","title":"Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake","status":"COMPLETED","sponsor":"Indiana University","startDate":"2012-01","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT01513473","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-01-16","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":350},{"nctId":"NCT01831765","phase":"PHASE3","title":"Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-08-26","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":1290},{"nctId":"NCT01850615","phase":"PHASE3","title":"Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-09-23","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":323},{"nctId":"NCT01835431","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-10-17","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":362},{"nctId":"NCT03959865","phase":"","title":"GLP-1 REceptor Agonists and Real World EvIdeNce","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2018-12-19","conditions":"Type 2 Diabetes","enrollment":6000},{"nctId":"NCT02131272","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2014-06-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":42},{"nctId":"NCT02033889","phase":"PHASE3","title":"A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2013-12-13","conditions":"Type 2 Diabetes Mellitus","enrollment":621},{"nctId":"NCT02219750","phase":"PHASE4","title":"Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2013-08","conditions":"Diabetes","enrollment":181},{"nctId":"NCT02741687","phase":"PHASE4","title":"Sitagliptin in Non-Diabetic Patients Undergoing General Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-06","conditions":"Hyperglycemia","enrollment":80},{"nctId":"NCT00639626","phase":"PHASE2, PHASE3","title":"Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)","status":"TERMINATED","sponsor":"Nationwide Children's Hospital","startDate":"2008-08","conditions":"Cystic Fibrosis Related Diabetes","enrollment":6},{"nctId":"NCT02302716","phase":"PHASE3","title":"A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 2","enrollment":493},{"nctId":"NCT00117780","phase":"PHASE4","title":"Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-06","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":520},{"nctId":"NCT01232491","phase":"PHASE4","title":"Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-10-29","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":611},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT00978627","phase":"PHASE3","title":"Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-08","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":548},{"nctId":"NCT01486966","phase":"PHASE4","title":"Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2011-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":58},{"nctId":"NCT00789191","phase":"PHASE3","title":"Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":222},{"nctId":"NCT00537303","phase":"PHASE4","title":"Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":296},{"nctId":"NCT00909480","phase":"PHASE4","title":"Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":457},{"nctId":"NCT00435019","phase":"PHASE3","title":"Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":348},{"nctId":"NCT00634842","phase":"PHASE4","title":"Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":244},{"nctId":"NCT00184600","phase":"PHASE3","title":"Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":708},{"nctId":"NCT00856986","phase":"PHASE3","title":"The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":987},{"nctId":"NCT01074268","phase":"PHASE3","title":"Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":456},{"nctId":"NCT01868542","phase":"PHASE4","title":"A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":46},{"nctId":"NCT00841087","phase":"PHASE2","title":"Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-01","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":65},{"nctId":"NCT01165684","phase":"PHASE4","title":"Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":401},{"nctId":"NCT00825643","phase":"","title":"Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":18481},{"nctId":"NCT00740519","phase":"","title":"Observational Study on Safety of Self-titration of Once Daily Levemir®","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":882},{"nctId":"NCT01043510","phase":"PHASE1","title":"The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":63},{"nctId":"NCT01135927","phase":"PHASE1","title":"A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-06","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":22},{"nctId":"NCT01068652","phase":"PHASE4","title":"Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":403},{"nctId":"NCT00842192","phase":"","title":"An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":2155},{"nctId":"NCT00623194","phase":"PHASE3","title":"Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":146},{"nctId":"NCT00865397","phase":"","title":"Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":1032},{"nctId":"NCT00806897","phase":"","title":"Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":74},{"nctId":"NCT01545791","phase":"","title":"Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-05","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":1037},{"nctId":"NCT00687284","phase":"","title":"Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":2188},{"nctId":"NCT02360254","phase":"","title":"Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Padova","startDate":"2015-01","conditions":"Type 1 Diabetes Mellitus","enrollment":26},{"nctId":"NCT00795600","phase":"PHASE4","title":"Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":60},{"nctId":"NCT00657930","phase":"","title":"Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":2289},{"nctId":"NCT01003184","phase":"PHASE3","title":"Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-10","conditions":"Type 2 Diabetes Mellitus","enrollment":222},{"nctId":"NCT01011868","phase":"PHASE2","title":"Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2009-11","conditions":"Diabetes Mellitus, Type 2","enrollment":494},{"nctId":"NCT00590226","phase":"PHASE4","title":"Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-12","conditions":"Type 2 Diabetes","enrollment":130},{"nctId":"NCT01974544","phase":"NA","title":"Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines","status":"UNKNOWN","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2013-05","conditions":"Type 2 Diabetes","enrollment":150},{"nctId":"NCT01828970","phase":"PHASE4","title":"Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients","status":"COMPLETED","sponsor":"Centre Europeen d'Etude du Diabete","startDate":"2010-01","conditions":"Diabetes Mellitus","enrollment":38},{"nctId":"NCT00542399","phase":"PHASE4","title":"Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections","status":"COMPLETED","sponsor":"Rabin Medical Center","startDate":"2007-11","conditions":"Type 1 Diabetes Mellitus","enrollment":50},{"nctId":"NCT00717288","phase":"PHASE4","title":"Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2008-07","conditions":"Diabetes Mellitus","enrollment":82},{"nctId":"NCT01076842","phase":"PHASE4","title":"Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-04","conditions":"Diabetes Type 2","enrollment":75},{"nctId":"NCT01310452","phase":"NA","title":"Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2011-01","conditions":"Type 2 Diabetes Mellitus","enrollment":50},{"nctId":"NCT01271517","phase":"PHASE4","title":"Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis","status":"UNKNOWN","sponsor":"Karolinska Institutet","startDate":"2005-09","conditions":"Diabetes Mellitus Type 1","enrollment":120},{"nctId":"NCT00457093","phase":"NA","title":"A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes","status":"COMPLETED","sponsor":"Diabetes Care Center","startDate":"2006-10","conditions":"Type 2 Diabetes","enrollment":35},{"nctId":"NCT00742976","phase":"PHASE4","title":"Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2008-06","conditions":"Diabetes Type 2, Weight Gain","enrollment":24},{"nctId":"NCT00271284","phase":"PHASE3","title":"Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2005-10","conditions":"Diabetes Mellitus, Type 1","enrollment":88},{"nctId":"NCT00494013","phase":"PHASE3","title":"Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2007-08","conditions":"Diabetes Mellitus Type 2","enrollment":442},{"nctId":"NCT00405418","phase":"PHASE4","title":"Lantus Versus Levemir Treat-To-Target","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-11","conditions":"Diabetes Mellitus, Type 2","enrollment":973}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":38,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Levemir"],"phase":"phase_3","status":"active","brandName":"Once-daily insulin detemir","genericName":"Once-daily insulin detemir","companyName":"Sydney Children's Hospitals Network","companyId":"sydney-children-s-hospitals-network","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin detemir is a long-acting basal insulin that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues while suppressing hepatic glucose production. Used for Type 1 diabetes mellitus in pediatric patients, Type 2 diabetes mellitus in pediatric patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}